TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18515187

Group type: EXPERIMENTAL
Intervention: Choice of intervention (Group format)
Number of subjects: 1075

Group type: COMPARATOR
Intervention: Assigned Group format
Number of subjects: 1075
Study: 15893155

Group type: EXPERIMENTAL
Intervention: 5 mg HYD/500 mg ACET
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mg HYD/500 mg ACET
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg HYD/1000 mg ACET
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 40 mg morphine sulfate (MOR)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1000 mg ACET
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12739903

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 38
Study: 10526246

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) for 6 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo for 6 months
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: GHD patients
Number of subjects: 22
Study: 7978473

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (30 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidural alfentanil (300 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidural alfentanil (1,000 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (3 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (10 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2563735

Group type: EXPERIMENTAL
Intervention: Euglycemic clamp protocol (plasma glucose approximately 5.6 mmol/L) for 4 h
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyperglycemic clamp protocol (plasma glucose about 11 mmol/L) for 4 h
Number of subjects: 20
Study: 1102147

Group type: EXPERIMENTAL
Intervention: Intra-nasal grass pollen extract
Number of subjects: 42

Group type: COMPARATOR
Intervention: Carbol saline (placebo)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nasal hyposensitization
Number of subjects: 42
Study: 31330091

Group type: EXPERIMENTAL
Intervention: Dementia patients
Number of subjects: 81192

Group type: COMPARATOR
Intervention: Controls (age- and gender-matched, no dementia diagnosis)
Number of subjects: 81192

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 81192
Study: 31697873

Group type: EXPERIMENTAL
Intervention: Elexacaftor-tezacaftor-ivacaftor
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 28188418

Group type: EXPERIMENTAL
Intervention: Prophylactic nimodipine treatment
Number of subjects: 112
Study: 25300574

Group type: EXPERIMENTAL
Intervention: Oral ginger
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study: 24320723

Group type: EXPERIMENTAL
Intervention: Cooking with Kids (CWK) program including a 1-hour introductory lesson, three 2-hour cooking classes, and three 1-hour fruit and vegetable tasting sessions for one semester.
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Cooking with Kids (CWK) program
Number of subjects: 257
Study: 21302483

Group type: EXPERIMENTAL
Intervention: Rhodiola
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no Rhodiola)
Number of subjects: 42
Study: 18097218

Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir monotherapy
Number of subjects: 205

Group type: COMPARATOR
Intervention: Triple therapy (lopinavir-ritonavir and two nucleosides)
Number of subjects: 205
Study: 16472960

Group type: EXPERIMENTAL
Intervention: Text-picture versions of instructions for inhaler chamber
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Text-picture versions of instructions for peak flow meter
Number of subjects: 99

Group type: COMPARATOR
Intervention: Original text-only versions of instructions for inhaler chamber
Number of subjects: 99

Group type: COMPARATOR
Intervention: Original text-only versions of instructions for peak flow meter
Number of subjects: 99
Study: 12500080

Group type: EXPERIMENTAL
Intervention: Sleep quality and quantity (measured by sleep efficiency and sleep latency)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Shorter sleep duration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sleep latency
Number of subjects: 60
Study: 10802845

Group type: EXPERIMENTAL
Intervention: Maternal Care Manual of the Perinatal Education Program
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control towns (no intervention)
Number of subjects: 73
Study: 9368551

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t-PA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 0
Study: 1329482

Group type: EXPERIMENTAL
Intervention: Low-fat plus high-fiber diet
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 3

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 3
Study: 3932050

Group type: EXPERIMENTAL
Intervention: Misoprostol 100 micrograms q.i.d.
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms q.i.d.
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Misoprostol 100 micrograms
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Misoprostol 25 micrograms
Number of subjects: 299
Study: 30735341

Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy with low weight transvaginal polypropylene mesh
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Synthetic mesh for POP surgery correction
Number of subjects: 1
Study: 29397524

Group type: EXPERIMENTAL
Intervention: Atrial synchronous biventricular pacing (CRT-P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AV node ablation
Number of subjects: 0
Study: 26873942

Group type: EXPERIMENTAL
Intervention: Continuous monitoring using an implantable loop recorder plus standard monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard heart rhythm monitoring alone
Number of subjects: 0
Study: 25284162

Group type: EXPERIMENTAL
Intervention: IPS supported employment service
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control condition (referral to other disability employment services)
Number of subjects: 208
Study: 22827512

Group type: EXPERIMENTAL
Intervention: Cooling jacket (Cryovest; V)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cool water immersion (20 °C; CWI)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive control (PAS)
Number of subjects: 9
Study: 19802729

Group type: EXPERIMENTAL
Intervention: PCI with distal protection devices (DPDs)
Number of subjects: 96
Study: 17644629

Group type: EXPERIMENTAL
Intervention: HA enriched commercial embryo transfer medium
Number of subjects: 101

Group type: COMPARATOR
Intervention: Routine embryo transfer medium without HA
Number of subjects: 101
Study: 15619390

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5 to 25.0 mg/day)
Number of subjects: 4732

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4732

Group type: COMPARATOR
Intervention: Placebo (subjects who developed diabetes during the trial)
Number of subjects: 4732

Group type: EXPERIMENTAL
Intervention: Diuretic therapy (subjects who developed diabetes during treatment)
Number of subjects: 4732

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (in subjects with diabetes)
Number of subjects: 4732
Study: 11871954

Group type: EXPERIMENTAL
Intervention: 10 degrees head-up tilt
Number of subjects: 40

Group type: COMPARATOR
Intervention: Horizontal position (Control)
Number of subjects: 40
Study: 10190266

Group type: EXPERIMENTAL
Intervention: 677C-->T mutation analysis in patients with neural tube defects and their parents
Number of subjects: 91

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 91
Study: 7749698

Group type: EXPERIMENTAL
Intervention: Local injection of adrenaline (1:10,000) followed by heater probe thermocoagulation
Number of subjects: 153

Group type: COMPARATOR
Intervention: No endoscopic treatment
Number of subjects: 153
Study: 1921531

Group type: EXPERIMENTAL
Intervention: Protocol for characterizing drug-related problems
Number of subjects: 706
Study: 7108059

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30003839

Group type: EXPERIMENTAL
Intervention: Brief guided cognitive behavioral treatment (CBT) for perfectionism delivered via a self-help booklet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 60
Study: 29580940

Group type: EXPERIMENTAL
Intervention: Self-efficacy (measured with the Self-Efficacy of Managing Chronic Disease questionnaire - SEMCD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Functional capacity (measured with the Prosthesis Evaluation Questionnaire–Mobility Scale - PEQ-MS)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Disability (measured with WHODAS 2.0)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Controlling for SEMCD
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Mediation analysis
Number of subjects: 38
Study: 27477473

Group type: EXPERIMENTAL
Intervention: Cervicothoracic manual therapy plus exercise therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 140
Study: 23961726

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP)
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Methadone (MET)
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Buprenorphine/naloxone (BUP) vs Methadone (MET)
Number of subjects: 1267
Study: 22340428

Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (100 mg single-dose)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (500 mg single-dose)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: JNJ-38431055 (500 mg once daily for 14 days)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sitagliptin (100 mg single-dose)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 20090397

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) consisting of ten consecutive weekly sessions
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study: 17678902

Group type: EXPERIMENTAL
Intervention: Oral desogestrel (n = 30) for 10 days combined with a tablet of raloxifene (60 mg) per vaginam (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral desogestrel at 60 mg/day (n = 30; group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral danazol at 200 mg, three times a day (n = 30; group C)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 90
Study: 16236844

Group type: EXPERIMENTAL
Intervention: Inhaled nebulized racemic glycopyrrolate (0.5, 1.0, and 2.0 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ipratropium bromide (0.5 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12111288

Group type: EXPERIMENTAL
Intervention: Weightlifters (WL)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Handball players (HP)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Amateur road cyclists (RC)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Middle-distance runners (MDR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Age-matched control subjects (C)
Number of subjects: 70
Study: 10543650

Group type: EXPERIMENTAL
Intervention: 100 mL of nonionic contrast material (300 mg I/mL) at 2 mL/s
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 100 mL of nonionic contrast material (300 mg I/mL) at 1.5 mL/s
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 100 mL of nonionic contrast material (300 mg I/mL) at 3 mL/s
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 100 mL of nonionic contrast material (300 mg I/mL) at 4 mL/s
Number of subjects: 97
Study: 7762723

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination (first dose)
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination (two doses)
Number of subjects: 1386

Group type: EXPERIMENTAL
Intervention: Ongoing vaccination program
Number of subjects: 1386
Study: 1702885

Group type: EXPERIMENTAL
Intervention: Gordox therapy (2 M IU within 20 min after induction, followed by 0.5 M IU/hour infusion until end of operation)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gordox therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 206826

Group type: EXPERIMENTAL
Intervention: Clofibate and beta-pyridylcarbinol (1.000 mg clofibrate and 50 mg beta-pyridylcarbinol per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Clofibate (1.500 mg per day)
Number of subjects: 27
Study: 31916571

Group type: EXPERIMENTAL
Intervention: Endometrial biopsy during ovarian stimulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Secretome analysis of cultured and decidualized endometrial stromal cells (EnSCs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isolation and culture of EnSCs
Number of subjects: 18
Study: 31380421

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement (MA) bite block
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard management (standard bite block and standard nasal cannula)
Number of subjects: 153
Study: 27915261

Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control clusters
Number of subjects: 0
Study: 25873303

Group type: EXPERIMENTAL
Intervention: Citalopram plus vitamin C
Number of subjects: 43

Group type: COMPARATOR
Intervention: Citalopram plus placebo
Number of subjects: 43
Study: 24320432

Group type: EXPERIMENTAL
Intervention: CVT algorithm for catheter optimization
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CVT algorithm with implantation errors
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CVT algorithm parameters
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CVT algorithm optimization time
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Breast HDR brachytherapy
Number of subjects: 8
Study: 22221594

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 19606169

Group type: EXPERIMENTAL
Intervention: Cryoirrigation at 12°C
Number of subjects: 38

Group type: COMPARATOR
Intervention: Room temperature irrigation at 25°C
Number of subjects: 38
Study: 17257756

Group type: EXPERIMENTAL
Intervention: Acupuncture (12 sessions over 8 weeks)
Number of subjects: 864

Group type: COMPARATOR
Intervention: Minimal (sham) acupuncture (superficial needling of non-acupuncture points)
Number of subjects: 864
Study: 15203290

Group type: EXPERIMENTAL
Intervention: Ethanol (0.6 g/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11445473

Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open nephrectomy
Number of subjects: 20
Study: 9568752

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Simvastatin 40 mg daily plus cholestyramine 4 g daily
Number of subjects: 32
Study: 7887103

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% wound infiltration (10 ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no infiltration)
Number of subjects: 40
Study: 3229340

Group type: EXPERIMENTAL
Intervention: Zindotrine 300 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29514224

Group type: EXPERIMENTAL
Intervention: ERAS pathway
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 226
Study: 27450203

Group type: EXPERIMENTAL
Intervention: Deeper cooling (32 °C for 120 h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer cooling (120 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cooling (33.5 °C for 72 h)
Number of subjects: 0
Study: 24691410

Group type: EXPERIMENTAL
Intervention: SWAP‐DM2
Number of subjects: 2219
Study: 22918966

Group type: EXPERIMENTAL
Intervention: Olanzapine (5‐20 mg/day)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 20371584

Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 223

Group type: COMPARATOR
Intervention: Non-treated patients
Number of subjects: 223
Study: 18535188

Group type: EXPERIMENTAL
Intervention: Positive parental history of diabetes
Number of subjects: 359

Group type: COMPARATOR
Intervention: Negative parental history of diabetes
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Individuals with two diabetic parents
Number of subjects: 359
Study: 15920052

Group type: EXPERIMENTAL
Intervention: Kidney-islet group (17 patients with islet transplant)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Kidney-only group (25 patients without islet transplant)
Number of subjects: 42
Study: 12217805

Group type: COMPARATOR
Intervention: MP alone
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: VAD/MP
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: VND/MP
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: VAD/MP and VND/MP
Number of subjects: 527
Study: 10600086

Group type: EXPERIMENTAL
Intervention: Amprenavir 1200 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amprenavir 1200 mg plus Ketoconazole 400 mg
Number of subjects: 12
Study: 8743497

Group type: EXPERIMENTAL
Intervention: Low protein diet (0.58 g/kg body wt/day)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Low blood pressure goal (92 mm Hg)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Very low protein diet (0.28 g/kg body wt/day supplemented with keto acids and amino acids)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Usual protein diet (1.3 g/kg body wt/day)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Usual blood pressure (107 mm Hg)
Number of subjects: 840
Study: 1817915

Group type: EXPERIMENTAL
Intervention: Ultrasonic root cleansing with 0.1% chlorhexidine gluconate as a coolant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ultrasonic root cleansing without chlorhexidine gluconate
Number of subjects: 10
Study: 7046604

Group type: EXPERIMENTAL
Intervention: Local Anaesthesia (LA)
Number of subjects: 103

Group type: COMPARATOR
Intervention: General Anaesthesia (GA)
Number of subjects: 103
Study: 31806073

Group type: EXPERIMENTAL
Intervention: High-resource setting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-resource setting
Number of subjects: 10
Study: 30894658

Group type: EXPERIMENTAL
Intervention: Sitting-up position (head elevated ≥30°)
Number of subjects: 9156

Group type: COMPARATOR
Intervention: Lying-flat position (0°)
Number of subjects: 9156

Group type: EXPERIMENTAL
Intervention: Overall association of CV of systolic BP (SBP)
Number of subjects: 9156
Study: 28835586

Group type: EXPERIMENTAL
Intervention: ≤15 mg/day additive tolvaptan (TLV)
Number of subjects: 81

Group type: COMPARATOR
Intervention: ≤40 mg/day increased furosemide (FUR)
Number of subjects: 81
Study: 26911639

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1,600 mg once daily
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1,200 mg once daily
Number of subjects: 2
Study: 24362944

Group type: EXPERIMENTAL
Intervention: Telaprevir (TVR) plus PEG‐IFN and ribavirin therapy
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Telaprevir (TVR) plus PEG‐IFN and ribavirin therapy with IFNL4 TT/TT genotype
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Telaprevir (TVR) plus PEG‐IFN and ribavirin therapy with IFNL4 TT/ΔG or ΔG/ΔG genotypes
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Telaprevir (TVR) at a reduced dose of 1,500 mg per day
Number of subjects: 87

Group type: COMPARATOR
Intervention: Younger patients (≤65 years) receiving the same therapy
Number of subjects: 87
Study: 22371012

Group type: EXPERIMENTAL
Intervention: Parent reports
Number of subjects: 270

Group type: COMPARATOR
Intervention: Teacher reports
Number of subjects: 270
Study: 19386059

Group type: EXPERIMENTAL
Intervention: 8-week walking program
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Maintenance stage walking
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lower education level
Number of subjects: 128
Study: 17570908

Group type: EXPERIMENTAL
Intervention: Buprenorphine at peak level
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Methadone at peak level
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Methadone at trough level
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Trough level (both substances)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medication-free control group
Number of subjects: 40
Study: 15468027

Group type: EXPERIMENTAL
Intervention: Multiwavelength light therapy (14 sessions, 3 times a week, energy used was 4.5 J/cm(2))
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham treatment (control group)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Multiwavelength light therapy (for stage 3 and 4 ulcers)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham treatment (control group for stage 3 and 4 ulcers)
Number of subjects: 35
Study: 11696741

Group type: COMPARATOR
Intervention: 5 mg. oxybutynin orally
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Passive diffusion of 5 mg. oxybutynin intravesically
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Electromotive administration of 15 mg. oxybutynin
Number of subjects: 12
Study: 9710387

Group type: EXPERIMENTAL
Intervention: Music during surgery
Number of subjects: 78

Group type: COMPARATOR
Intervention: No music
Number of subjects: 78

Group type: COMPARATOR
Intervention: Music and No music
Number of subjects: 78
Study: 8027416

Group type: EXPERIMENTAL
Intervention: Levodopa (up to 7 mg/kg per day) and Carbidopa (100 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsules (four times a day)
Number of subjects: 50
Study: 2678794

Group type: EXPERIMENTAL
Intervention: Pimobendan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 4348345

Group type: EXPERIMENTAL
Intervention: p-hydroxynorephedrine (PHN) 600 mg daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8